<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Carbohydrate <z:chebi fb="0" ids="28800">N-acetylgalactosamine</z:chebi> 4-0 sulfotransferase 9 (CHST9) belongs to the <z:chebi fb="0" ids="28800">N-acetylgalactosamine</z:chebi> 4-sulfotransferase (GalNAc4ST) family </plain></SENT>
<SENT sid="1" pm="."><plain>A recent array-based study implicated the presence of copy-number variations (CNV) of the region encompassing CHST9 in the genomes of <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Most of the current studies, however, focused on the genome-wide screening of CNV, and the functional impact of such regions needs to be extensively investigated in large amounts of clinical samples </plain></SENT>
<SENT sid="3" pm="."><plain>In our study, we collected 617 bone marrow samples from multi-types of <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e>, as well as healthy controls, and detected the CNV of CHST9 by real-time polymerase chain reaction (PCR) </plain></SENT>
<SENT sid="4" pm="."><plain>We found significant association between the CNV of CHST9 and these <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> including <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo>, <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo>, <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>, <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo>, <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo>, and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>We also examined CHST9 <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression in the samples with one or two copies of DNA, and observed a weak yet positive correlation between the relative expression level and gene dosage </plain></SENT>
<SENT sid="6" pm="."><plain>In general, the CNV of CHST9 have been shown to associate with <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The functional consequences of CNV, however, need to be investigated extensively in the future </plain></SENT>
</text></document>